Press-release for stocks for azn

symbols : Azn

save search

Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Report 2022 with Competitive Landscape Analysis of Eli Lily and Co; Novartis; Bristol-Myers Squibb; Roche Diagnostics; Sanofi
Published: 2022-06-17 (Crawled : 12:20) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

Health Technology

| -24.07% | O: 0.01% H: 0.17% C: 0.17%
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -3.0% | O: -1.76% H: 5.75% C: 5.5%
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology

| 18.15% | O: 1.89% H: 0.0% C: -0.64%
NVSEF | News | $96.0 6.88% 52K

Health Technology

| 42.43% | O: 0.74% H: 0.52% C: -3.23%
NVS | News | $98.35 1.1% 0.0% 2.2M

Health Technology

| 21.4% | O: 0.07% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

Health Technology

| -0.6% | O: -0.24% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M

Health Technology

| -32.4% | O: 0.57% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -3.12% | O: 1.39% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 16.43% | O: 0.59% H: 0.0% C: 0.0%
active report roche sanofi market diagnostic

Global Targeted Drug Delivery Market 2022-2030 with 2021 as the Base Year
Published: 2022-06-17 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -3.0% | O: -1.76% H: 5.75% C: 5.5%
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology

| 18.15% | O: 1.89% H: 0.0% C: -0.64%
BSX | $72.91 5.68% -0.03% 15M

Health Technology

| 97.11% | O: 1.69% H: 2.14% C: 1.18%
BAX | $40.93 -0.22% 0.0% 2.2M

Health Technology

| -38.4% | O: -1.77% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

Health Technology

| 24.26% | O: 1.05% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -3.12% | O: 1.39% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 16.43% | O: 0.59% H: 0.0% C: 0.0%
ARWR | $23.285 -2.08% -2.13% 810K

Health Technology

| -15.61% | O: 0.67% H: 7.55% C: 2.64%
drug year market

TROPION-Breast02 Phase 3 Trial of Datopotamab Deruxtecan Initiated in Patients with Previously Untreated Metastatic Triple Negative Breast Cancer
Published: 2022-06-13 (Crawled : 13:00) - biospace.com/
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 15.6% | O: -1.4% H: 0.4% C: -0.7%
trial cancer negative initiated breast cancer phase 3

Breakthroughs In Treating Killer Diseases Could Lengthen Life
Published: 2022-06-07 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

Health Technology

| -28.95% | O: 0.0% H: 0.86% C: 0.84%
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology

| 11.7% | O: 4.83% H: 0.0% C: -5.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -15.57% | O: -0.18% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

Health Technology

| -3.67% | O: 0.37% H: 3.03% C: 2.98%
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 134.87% | O: -3.62% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 11.54% | O: 0.54% H: 2.78% C: 2.69%
life disease

Global Cancer Cachexia Market to Reach $2.7 Billion by 2026
Published: 2022-06-03 (Crawled : 14:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology

| 9.0% | O: -0.4% H: 4.05% C: -1.35%
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 138.4% | O: -2.25% H: 0.0% C: 0.0%
AVEO | $15.0 0.0% 0

Health Technology

| 255.33% | O: -0.71% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 6.56% | O: -0.56% H: 0.82% C: -0.64%
cancer market

Idiopathic Pulmonary Fibrosis Market Size to hit USD 5326.8 Million in 2028 | Growing at 7.1 % CAGR, Says Brandessence Market Research
Published: 2022-06-03 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology

| 9.0% | O: -0.4% H: 4.05% C: -1.35%
BMY | $48.86 -0.27% -0.02% 16M

Health Technology

| -35.09% | O: -1.4% H: 0.0% C: 0.0%
GLPG | News | $28.78 -2.28% -2.33% 140K

Health Technology

| -47.37% | O: 0.29% H: 2.68% C: 2.39%
FGEN | $0.9844 -8.0% -8.7% 2.2M

Health Technology

| -88.8% | O: 1.57% H: 2.99% C: 2.99%
BIIB | $201.91 4.52% 4.32% 3.3M

Health Technology

| -1.35% | O: 1.16% H: 3.3% C: 1.27%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 6.56% | O: -0.56% H: 0.82% C: -0.64%
fibrosis research growing market

Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer
Published: 2022-06-03 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300

Health Technology

| -12.54% | O: 1.65% H: 0.0% C: -0.32%
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -11.71% | O: -0.94% H: 0.0% C: 0.0%
NVO | News | $126.16 -1.93% -0.23% 3.1M

Health Technology

| 15.37% | O: 0.65% H: 0.63% C: 0.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -12.28% | O: -0.09% H: 0.0% C: 0.0%
IPHA | $2.47 4.22% 4.05% 690

Health Technology

| -19.99% | O: 2.96% H: 0.98% C: -1.15%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 6.56% | O: -0.56% H: 0.82% C: -0.64%
iph5201 pharma cancer phase 2

Global Panic Disorders Market Insights | Size | Shares | Trends | Growth | Industry Analysis [2020-2030] Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. PET-CT Scanner Devices Market: Competitive Landscape Analysis With Forecast by 2031 Wilmington, Delaware: According to the report, the global PET-CT scanner devices market was valued over US$ 200 Mn in 2020 and is projected to expand at a CAGR of ~3% from 2021 to 2031. Portal Hypertension Market Insights | Current Trends | Growth Opportunity | Global Industry Analysis [2020-2030] At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. Spatial Genomics & Transcriptomics Market to Experience Significant Growth by 2027 Wilmington, Delaware: The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027. Teleradiology Services Market to Make Great Impact in Near Future by 2031 Wilmington, Delaware: According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. Anti-depressants Drugs and Therapies Market to Witness a Pronounce Growth by 2025 Wilmington, Delaware: Anti-depressants medications lower the symptoms of depression, dysthymia, chronic depression, and anxiety disorders. B-Cell Non-Hodgkin’s Lymphoma (NHL) Market to Offer Ample Growth Opportunities by 2027 Wilmington, Delaware: Non-Hodgkin’s lymphoma is a group of heterogeneous proliferative malignancies. Heightening Healthcare Spending Opening Growth Avenues for Collateral Ligament Stabilizer System Market, Reaching US$ 3.5 Billion in 2032: Fact.MR Study Fact.MR – A Market Research and Competitive Intelligence Provider: The global collateral ligament stabilizer system market is expected to reach US$ 3.5 Billion by the end of the 2022-2032 forecast period, growing at a CAGR of 6.1%, concludes a recently published report by Fact.MR. Breast Cancer Liquid Biopsy Market Trends, Growth, Analysis and Future Scope, 2026 Wilmington, Delaware: A biopsy is a tissue or cell sample taken from any part of the patient’s body and examined in the lab for the detection of cancer. Cerebral Palsy Market Size, Shares, Trends and Growth | Global Industry Analysis [2020-2030] The global cerebral palsy market is picking up steam due to increasing awareness about the condition amongst parents. Continuous Glucose Monitoring Market: Competitive Research and Precise Outlook 2021 to 2028 Wilmington, Delaware: The global continuous glucose monitoring market depicts the presence of a large competitive vendor landscape, says Transparency Market Research on the basis of a newly research report. Crow’s Feet Market Key Trends and Opportunity Analysis up to 2026 Albany NY, United States: The demand within the global crow’s feet market has been escalating on account of vital advancements in the field of dermatology in recent times. HIV Associated Lipodystrophy Syndrome Market Insights | Global Industry Analysis [2020-2030] HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus -infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Global Mail Service Pharmacy Market | Size | Shares | Trends | Growth | Forecast [2020-2030]
Published: 2022-06-03 (Crawled : 06:00) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K

Health Technology

| -26.78% | O: -1.55% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -11.71% | O: -0.94% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology

| 9.0% | O: -0.4% H: 4.05% C: -1.35%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -49.67% | O: 0.57% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

Health Technology

| -4.6% | O: -0.14% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 138.4% | O: -2.25% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M

Health Technology

| -35.09% | O: -1.4% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -12.28% | O: -0.09% H: 0.0% C: 0.0%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K

Health Technology

| 52.15% | O: 2.29% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 6.56% | O: -0.56% H: 0.82% C: -0.64%
lipodystrophy treatment research system active services report service growing hiv profitable hypertension genomics expected virus approval cancer growth group market breast cancer infections

GRAIL Announces Strategic Collaboration With AstraZeneca to Develop Companion Diagnostic Tests to Enable the Treatment of Early-Stage Cancer
Published: 2022-06-02 (Crawled : 17:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M

Health Technology

| -47.08% | O: -0.03% H: 5.85% C: 5.7%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 7.15% | O: 0.56% H: 0.0% C: 0.0%
treatment collaboration diagnostic cancer test

GlobalData Plc: North America Accounted for Highest Number of Social Anxiety Disorder Clinical Trials Conducted in 2022
Published: 2022-06-02 (Crawled : 16:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology

| 6.18% | O: 0.97% H: 0.19% C: -3.52%
NVSEF | News | $96.0 6.88% 52K

Health Technology

| 28.57% | O: -0.31% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M

Health Technology

| 9.41% | O: -0.73% H: 0.12% C: 0.1%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -15.78% | O: 0.01% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

Health Technology

| -4.18% | O: 0.44% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 7.15% | O: 0.56% H: 0.0% C: 0.0%
america trials social anxiety disorder

ChemoCentryx Announces Changes to its Board of Directors
Published: 2022-05-31 (Crawled : 21:00) - ir.chemocentryx.com
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology